Related Experiment Video
Updated: Jul 29, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Systemic immune-inflammation index associated with contrast-induced nephropathy after elective percutaneous coronary
Xiao Ma1, Changhua Mo, Yujuan Li
1Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University & Guangxi Key Laboratory Base of Precision Medicine in Cardiocerebrovascular Diseases Control and Prevention & Guangxi Clinical Research Center for Cardiocerebrovascular Diseases, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Insights
Elevated systemic immune-inflammation index (SII) is a risk factor for contrast-induced nephropathy (CIN) after elective percutaneous coronary intervention (PCI). This association is particularly strong in male patients, highlighting SII as a potential predictive biomarker.
Area of Science:
- Cardiology
- Nephrology
- Immunology
Background:
- Elevated systemic immune-inflammation index (SII) is linked to coronary heart disease and adverse outcomes.
- The association between SII and contrast-induced nephropathy (CIN) in patients undergoing elective percutaneous coronary intervention (PCI) remains unclear.
Purpose of the Study:
- To investigate the relationship between SII and the development of CIN in patients undergoing elective PCI.
- To identify SII as a potential predictive biomarker for CIN in this patient population.
Main Methods:
- Retrospective study of 241 patients undergoing elective PCI between March 2018 and July 2020.
- CIN defined by serum creatinine increase (≥0.5 mg/dL or ≥25% from baseline) within 48-72 hours post-PCI.
- Correlation analysis, multivariate logistic regression, and receiver operating characteristic (ROC) curve analysis were performed.
Main Results:
- Patients with CIN exhibited significantly higher SII levels compared to those without.
- SII positively correlated with uric acid and negatively with estimated glomerular filtration rate.
- Elevated log2(SII) was an independent risk factor for CIN (OR=2.686), especially in males (OR=3.669).
- ROC analysis indicated an SII cutoff of 586.19 for predicting CIN with 75% sensitivity and 54.2% specificity.
Conclusions:
- Elevated SII is an independent risk factor for CIN development in patients undergoing elective PCI.
- The association between SII and CIN is more pronounced in male patients.
- SII may serve as a valuable predictive biomarker for CIN in elective PCI patients, particularly males.
Abstract:
Elevated systemic immune-inflammation index (SII) has associated with coronary heart disease and poor clinical outcomes. However, the relationship between SII and contrast-induced nephropathy (CIN) in patients who underwent elective percutaneous coronary intervention (PCI) is still unclear. We aimed to investigate the association of SII with the development of CIN in elective PCI patients. A retrospective study with 241 participants was performed from March 2018 to July 2020. CIN was defined as any of the following: increase in serum creatinine (SCr) level by ≥0.5 mg/dl (≥44.2 mol/L) or increase in SCr to ≥25% over the baseline value within 48-72 h after PCI. The SII levels in patients with CIN ( n = 40) were significantly higher than those without. In correlation analysis, SII positively correlated to uric acid but negatively with the estimated glomerular filtration rate. Increased log2(SII) levels were independent risk factors for patients with CIN [odds ratio (OR) = 2.686; 95% confidence interval (CI), 1.457-4.953]. In the subgroup analysis, increased log2(SII) was strongly associated with the presence of CIN in male participants (OR = 3.669; 95% CI, 1.925-6.992; P < 0.05), whereas no association was found in females (OR = 1.552; 95% CI, 0.533-4.515; P > 0.05). Receiver operating characteristic analysis demonstrated that in a cutoff of 586.19, SII showed 75% sensitivity and 54.2% specificity for predicting CIN in patients undergoing elective PCI, respectively. In conclusion, elevated SII was an independent risk factor of CIN development in patients undergoing elective PCI, particularly in male people.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:03Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pericarditis I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies